NCT06475183View on ClinicalTrials.gov

Probiotic Chocolate Study in Multiple Sclerosis

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

December 9, 2024

Study Completion Date

December 9, 2024

Conditions
Multiple SclerosisHealthy Nutrition
Interventions
DIETARY_SUPPLEMENT

Bouchard Belgian Dark Chocolate Probiotic Napolitains, containing bifidobacterium longum

Bouchard Belgian Dark Chocolate Probiotic Napolitains containing 10 billion CFUs of bifidobacterium longum daily for 6 weeks

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT06475183 - Probiotic Chocolate Study in Multiple Sclerosis | Biotech Hunter | Biotech Hunter